Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer

Titto Augustine, Peter John, Tyler Friedman, Jeeshan Jiffry, Hillary Guzik, Rifat Mannan, Riya Gupta, Catherine Delano, John M. Mariadason, Xingxing Zang, Radhashree Maitra, Sanjay Goel

Research output: Contribution to journalArticlepeer-review


The majority of colorectal cancers (CRCs) are microsatellite stable (MSS) and resistant to immunotherapy. The current study explores the possibility of using oncolytic reovirus to sensitize MSS CRC to immune checkpoint inhibition. While reovirus reduced metabolic activity among KRASMut cells, microarray/computational analysis revealed microsatellite status-oriented activation of immune-response pathways. Reovirus plus anti-PD-1 treatment increased cell death among MSS cells ex vivo. Reduced tumorigenicity and proliferative index, and increased apoptosis were evident among CT26 [MSS, KRASMut], but not in MC38 [microsatellite unstable/MSI, KRASWt] syngeneic mouse models under combinatorial treatment. PD-L1-PD-1 signaling axis were differentially altered among CT26/MC38 models. Combinatorial treatment activated the innate immune system, pattern recognition receptors, and antigen presentation markers. Furthermore, we observed the reduction of immunosuppressive macrophages and expansion of effector T cell subsets, as well as reduction in T cell exhaustion. The current investigation sheds light on the immunological mechanisms of the reovirus-anti-PD-1 combination to reduce the growth of MSS CRC.

Original languageEnglish (US)
Article number1018767
JournalFrontiers in Oncology
StatePublished - Oct 25 2022


  • anti-PD-1
  • colorectal cancer
  • combinatorial therapy
  • immune checkpoint
  • microsatellite instability
  • reovirus
  • translational

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer'. Together they form a unique fingerprint.

Cite this